CIK 0001816590 · Non-accelerated filer<br>Smaller reporting company
COMPASS Pathways plc
Sign in to watch- Ticker
- CMPS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 1-716-676-6461
- Business address
- 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESIRE, United Kingdom, WA14 2DT
- Former names
- Compass Rx Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-02 | Goodwin Guy Chief Medical Officer | Grant or award · Share Option (Right to Buy) | +10,800 | 21,600 | ||
| 2023-02-02 | Malievskaia Ekaterina Chief Innovation Officer | Grant or award | +11,700 | 4,272,019 | ||
| 2023-02-02 | Malievskaia Ekaterina Chief Innovation Officer | Grant or award · Share Option (Right to Buy) | +67,500 | 67,500 | ||
| 2023-02-02 | FALVEY MICHAEL Chief Financial Officer | Grant or award | +22,500 | 22,500 | ||
| 2023-02-02 | FALVEY MICHAEL Chief Financial Officer | Grant or award · Share Option (Right to Buy) | +45,000 | 45,000 | ||
| 2023-02-02 | OWENS MATTHEW A General Counsel & CLO | Grant or award | +10,800 | 21,507 | ||
| 2023-02-02 | OWENS MATTHEW A General Counsel & CLO | Grant or award · Share Option (Right to Buy) | +63,900 | 63,900 | ||
| 2023-02-02 | Goldsmith George Jay Director | Grant or award | +11,700 | 4,272,019 | ||
| 2023-02-02 | Goldsmith George Jay Director | Grant or award · Share Option (Right to Buy) | +67,500 | 67,500 | ||
| 2023-02-02 | Nath Kabir Chief Executive Officer | Grant or award | +25,200 | 75,200 | ||
| 2023-02-02 | Nath Kabir Chief Executive Officer | Grant or award · Share Option (Right to Buy) | +153,900 | 153,900 | ||
| 2023-02-01 | Malievskaia Ekaterina Chief Innovation Officer | Shares withheld for taxes | −3,301 | $10.61 | $35K | 4,260,319 |
| 2023-02-01 | Malievskaia Ekaterina Chief Innovation Officer | Shares withheld for taxes | −5,283 | $10.61 | $56K | 4,274,509 |
| 2023-02-01 | OWENS MATTHEW A General Counsel & CLO | Shares withheld for taxes | −1,693 | $10.61 | $18K | 10,707 |
| 2023-02-01 | Goldsmith George Jay Director | Shares withheld for taxes | −5,283 | $10.61 | $56K | 4,274,509 |
| 2023-02-01 | Goldsmith George Jay Director | Shares withheld for taxes | −3,301 | $10.61 | $35K | 4,260,319 |
| 2022-12-20 | Malievskaia Ekaterina Chief Innovation Officer | Shares withheld for taxes | −4,577 | $9.20 | $42K | 4,263,620 |
| 2022-12-20 | Malievskaia Ekaterina Chief Innovation Officer | Shares withheld for taxes | −4,409 | $9.20 | $41K | 4,279,792 |
| 2022-12-20 | Goldsmith George Jay Director | Shares withheld for taxes | −4,409 | $9.20 | $41K | 4,279,792 |
| 2022-12-20 | Goldsmith George Jay Director | Shares withheld for taxes | −4,577 | $9.20 | $42K | 4,263,620 |
Page 10 of 12 · 230 trades